NCT03357887View on ClinicalTrials.gov

Prognostic Value of Three New Biomarkers of Multiple Sclerosis in Patients With Radiologically Isolated Syndrome

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

Multiple SclerosisRadiologically Isolated Syndrome

Interventions

OTHER

Analysis of cerebrospinal fluid and serum

Analysis of biomarkers in patient biological samples

Trial Locations (1)

30029

CHU Nimes, Nîmes

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT03357887 - Prognostic Value of Three New Biomarkers of Multiple Sclerosis in Patients With Radiologically Isolated Syndrome | Biotech Hunter | Biotech Hunter